U.S. markets closed

ProQR Therapeutics N.V. (PRQR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.0000-0.0400 (-1.96%)
At close: 04:00PM EST
2.0000 0.00 (0.00%)
After hours: 07:52PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close2.0400
Bid2.0100 x 900
Ask2.0200 x 900
Day's Range1.9200 - 2.1300
52 Week Range1.1100 - 3.8500
Avg. Volume217,741
Market Cap162.315M
Beta (5Y Monthly)0.23
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for PRQR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ProQR Therapeutics N.V.
    QURE: Lowering target price to $8.00UNIQURE NV has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more